Average Co-Inventor Count = 2.25
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pneumrx, Inc. (17 from 47 patents)
2. Abbott Cardiovascular Systems, Inc. (12 from 1,185 patents)
3. C2 Therapeutics, Inc. (5 from 8 patents)
4. Advanced Cardiovascular Systems, Inc. (4 from 1,523 patents)
5. Abbott Vascular Solutions Inc. (4 from 8 patents)
6. Pentax of America, Inc. (3 from 18 patents)
7. Apreo Health, Inc. (2 from 4 patents)
8. Endovascular Technologies, Inc. (1 from 151 patents)
9. Mvrx, Inc. (1 from 30 patents)
49 patents:
1. 12458515 - Endobronchial implants and related technology
2. 12285345 - Endobronchial implants and related technology
3. 12239533 - Device, method and system for reshaping a heart valve annulus
4. 11266456 - Cryogenic ablation system with rotatable and translatable catheter
5. 10285707 - Enhanced efficacy lung volume reduction devices, methods, and systems
6. 10251693 - Cryogenic ablation system with rotatable and translatable catheter
7. 10226257 - Lung volume reduction devices, methods, and systems
8. 10188398 - Cross-sectional modification during deployment of an elongate lung volume reduction device
9. 10098686 - Cryogenic balloon ablation system
10. 10058331 - Enhanced efficacy lung volume reduction devices, methods, and systems
11. 9782558 - Minimally invasive lung volume reduction devices, methods, and systems
12. 9700364 - Cryogenic balloon ablation system
13. 9694116 - Stents with radiopaque markers
14. 9474533 - Cross-sectional modification during deployment of an elongate lung volume reduction device
15. 9452067 - Apparatus for attaching radiopaque markers to a stent